The expression of IL-8 and IL-8 receptors in pancreatic adenocarcinomas and pancreatic neuroendocrine tumours

Cytokine

Volumn 49, Issue 2, 2010, Pages 134-140

  Hussain, Farah ^a   Wang, Jayson ^a   Ahmed, Raida ^a   Guest, Stephanie K ^a   Lam, Eric W F ^a   Stamp, Gordon ^a   El Bahrawy, Mona ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Adenocarcinoma; Interleukin 8; Neuroendocrine tumours; Pancreas

Indexed keywords

INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PANCREAS ADENOCARCINOMA; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREAS; PANCREATIC NEOPLASMS; RECEPTORS, INTERLEUKIN-8; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 73649093726     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.11.010     Document Type: Article

References (34)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Akerele C.E., Rybalova I., Kaufman H.L., and Mani S. Current approaches to novel therapeutics in pancreatic cancer. Invest New Drugs 21 (2003) 113-129
3. Yeo T.P., Hruban R.H., Leach S.D., Wilentz R.E., Sohn T.A., Kern S.E., et al. Pancreatic cancer. Curr Probl Cancer 26 (2002) 176-275
4. Shi Q., Abbruzzese J.L., Huang S., Fidler I.J., Xiong Q., and Xie K. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res 5 (1999) 3711-3721
5. Klein A.P., Hruban R.H., Brune K.A., Petersen G.M., and Goggins M. Familial pancreatic cancer. Cancer J 7 (2001) 266-273
6. Talamini G., Falconi M., Bassi C., Sartori N., Salvia R., Caldiron E., et al. Incidence of cancer in the course of chronic pancreatitis. Am J Gastroenterol 94 (1999) 1253-1260
7. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12 (2001) 375-391
8. Mattei S., Colombo M.P., Melani C., Silvani A., Parmiani G., and Herlyn M. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56 (1994) 853-857
9. Green A.R., Green V.L., White M.C., and Speirs V. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours. Int J Cancer 72 (1997) 937-941
10. Brew R., Erikson J.S., West D.C., Kinsella A.R., Slavin J., and Christmas S.E. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12 (2000) 78-85
11. Ivarsson K., Ekerydh A., Fyhr I.M., Janson P.O., and Brannstrom M. Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor A in ovarian carcinomas. Acta Obstet Gynecol Scand 79 (2000) 777-784
12. Lee L.F., Schuerer-Maly C.C., Lofquist A.K., van Haaften-Day C., Ting J.P., White C.M., et al. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer. Cancer Res 56 (1996) 1303-1308
13. Tjiong M.Y., van der Vange N., ten Kate F.J., Tjong A.H.S.P., ter Schegget J., Burger M.P., et al. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecol Oncol 73 (1999) 285-291
14. Yasumoto K., Okamoto S., Mukaida N., Murakami S., Mai M., and Matsushima K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J Biol Chem 267 (1992) 22506-22511
15. Strieter R.M., Polverini P.J., Arenberg D.A., and Kunkel S.L. The role of CXC chemokines as regulators of angiogenesis. Shock 4 (1995) 155-160
16. Veltri R.W., Miller M.C., Zhao G., Ng A., Marley G.M., Wright Jr. G.L., et al. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Urology 53 (1999) 139-147
17. Konig B., Steinbach F., Janocha B., Drynda A., Stumm M., Philipp C., et al. The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma. Anticancer Res 19 (1999) 1519-1524
18. Weetman A.P., Bennett G.L., and Wong W.L. Thyroid follicular cells produce interleukin-8. J Clin Endocrinol Metab 75 (1992) 328-330
19. Wigmore S.J., Fearon K.C., Maingay J.P., Lai P.B., and Ross J.A. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol 273 (1997) E720-E726
20. Miyamoto M., Shimizu Y., Okada K., Kashii Y., Higuchi K., and Watanabe A. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells. Cancer Immunol Immunother 47 (1998) 47-57
21. Takamori H., Oades Z.G., Hoch O.C., Burger M., and Schraufstatter I.U. Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1. Pancreas 21 (2000) 52-56
22. Arnold R. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options. Best Pract Res Clin Gastroenterol 19 (2005) 491-505
23. Pavel M.E., Hassler G., Baum U., Hahn E.G., Lohmann T., and Schuppan D. Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas. Clin Endocrinol (Oxf) 62 (2005) 434-443
24. Ebrahimi B., Tucker S.L., Li D., Abbruzzese J.L., and Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101 (2004) 2727-2736
25. Kuwada Y., Sasaki T., Morinaka K., Kitadai Y., Mukaida N., and Chayama K. Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells. Int J Oncol 22 (2003) 765-771
26. Le X., Shi Q., Wang B., Xiong Q., Qian C., Peng Z., et al. Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma. J Interferon Cytokine Res 20 (2000) 935-946
27. Antony V.B., Hott J.W., Godbey S.W., and Holm K. Angiogenesis in mesotheliomas. Role of mesothelial cell derived IL-8. Chest 109 (1996) 21S-22S
28. Rosenkilde M.M., and Schwartz T.W. The chemokine system-a major regulator of angiogenesis in health and disease. Apmis 112 (2004) 481-495
29. Li A., Varney M.L., and Singh R.K. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 7 (2001) 3298-3304
30. Huang S., Mills L., Mian B., Tellez C., McCarty M., Yang X.D., et al. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol 161 (2002) 125-134
31. Strieter R.M., Burdick M.D., Gomperts B.N., Belperio J.A., and Keane M.P. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 16 (2005) 593-609
32. Tecimer T., Dlott J., Chuntharapai A., Martin A.W., and Peiper S.C. Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells. Arch Pathol Lab Med 124 (2000) 520-525
33. Li M., Zhang Y., Feurino L.W., Wang H., Fisher W.E., Brunicardi F.C., et al. Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer. Cancer Sci 99 (2008) 733-737
34. Wente M.N., Keane M.P., Burdick M.D., Friess H., Buchler M.W., Ceyhan G.O., et al. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. Cancer Lett 241 (2006) 221-227